We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-12.91%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$131B
AUM Growth
-$19.5B
Cap. Flow
+$2.76B
Cap. Flow %
2.11%
Top 10 Hldgs %
14.61%
Holding
3,199
New
67
Increased
1,772
Reduced
1,049
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$361M
2
CVS icon
CVS Health
CVS
+$180M
3
CI icon
Cigna
CI
+$158M
4
MSFT icon
Microsoft
MSFT
+$102M
5
AMZN icon
Amazon
AMZN
+$90M

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Financials 13.99%
3 Healthcare 13.63%
4 Industrials 10.39%
5 Consumer Discretionary 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASTH icon
2976
Astrana Health
ASTH
$1.76B
$259K ﹤0.01%
13,006
BW icon
2977
Babcock & Wilcox
BW
$1.39B
$258K ﹤0.01%
66,031
+5,256
+9% +$46.8K
CBFV icon
2978
CB Financial Services
CBFV
$186M
$258K ﹤0.01%
10,382
ABUS icon
2979
Arbutus Biopharma
ABUS
$857M
$253K ﹤0.01%
65,900
VIVS
2980
VivoSim Labs
VIVS
$1.2M
$253K ﹤0.01%
1,099
+119
+12% +$30K
USX
2981
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$252K ﹤0.01%
44,810
MPB icon
2982
Mid Penn Bancorp
MPB
$971M
$251K ﹤0.01%
10,896
-104
-0.9% -$2.67K
SND icon
2983
Smart Sand
SND
$185M
$250K ﹤0.01%
112,392
+12,111
+12% +$38.2K
VUZI icon
2984
Vuzix
VUZI
$194M
$250K ﹤0.01%
51,800
PVBC
2985
DELISTED
Provident Bancorp
PVBC
$249K ﹤0.01%
23,177
VATE icon
2986
INNOVATE Corp
VATE
$111M
$249K ﹤0.01%
9,411
XERS icon
2987
Xeris Biopharma Holdings
XERS
$1.39B
$247K ﹤0.01%
14,491
NAGE
2988
Niagen Bioscience
NAGE
$271M
$247K ﹤0.01%
71,800
FUNC icon
2989
First United
FUNC
$285M
$244K ﹤0.01%
15,275
CLFD icon
2990
Clearfield
CLFD
$411M
$243K ﹤0.01%
24,491
KA
2991
DELISTED
Kineta, Inc. Common Stock
KA
$243K ﹤0.01%
535
+200
+60% +$136K
EOLS icon
2992
Evolus
EOLS
$385M
$242K ﹤0.01%
20,326
+416
+2% +$5.93K
RMTI icon
2993
Rockwell Medical
RMTI
$28.4M
$242K ﹤0.01%
970
+75
+8% +$29.8K
OVLY icon
2994
Oak Valley Bancorp
OVLY
$285M
$240K ﹤0.01%
13,100
IOTS
2995
DELISTED
Adesto Technologies Corp
IOTS
$239K ﹤0.01%
54,290
SYBX
2996
DELISTED
Synlogic
SYBX
$235K ﹤0.01%
2,233
AMRS
2997
DELISTED
Amyris Inc.
AMRS
$235K ﹤0.01%
70,120
ESCA icon
2998
Escalade
ESCA
$273M
$234K ﹤0.01%
20,400
TLRA
2999
DELISTED
Telaria, Inc.
TLRA
$225K ﹤0.01%
82,400
FGBI icon
3000
First Guaranty Bancshares
FGBI
$159M
$224K ﹤0.01%
11,677

Similar funds

Charles Schwab's Q4 2018 Portfolio in Review

As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
  • Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
  • Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
  • Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
  • Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
  • Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
  • Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.

Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.